Related Experiment Videos
[Liver tissue-specific stable expression of human CD81 molecule]
Shuai-zheng Jia1, Li-ping Lu, Min-xia Liu
1Institute of Transfusion Medicine, Beijing 100850, China. jiasz@nic.bmi.ac.cn
Summary
Researchers successfully expressed the human CD81 gene in mouse hepatoma cells using a liver-specific promoter. This achievement enables further studies on hepatitis C virus (HCV) interactions and drug screening.
Area of Science:
- * Molecular Biology
- * Virology
- * Cell Biology
Background:
- * Hepatitis C virus (HCV) entry into host cells is mediated by host factors, including CD81.
- * Understanding the role of human CD81 in HCV infection is crucial for developing antiviral strategies.
Purpose of the Study:
- * To establish a stable expression system for the human CD81 gene in a mouse hepatoma cell line (Hepa 1-6).
- * To utilize a liver-specific promoter for targeted gene expression in Hepa 1-6 cells.
Main Methods:
- * Isolation of human CD81 gene from HepG2 cells and RT-PCR amplification.
- * Ligation of liver-specific albumin promoter/enhancer and SV40 polyA sequence to the CD81 gene.
- * Construction of a recombinant eukaryotic expression vector (pcDNA3-Alb p-CD81).
- * Transfection of the recombinant vector into Hepa 1-6 cells and confirmation of gene expression via RT-PCR and FACS.
Main Results:
- * Successful cloning and sequencing of the human CD81 gene.
- * Stable transcription of human CD81 mRNA confirmed in transfected Hepa 1-6 cells.
- * Stable expression of human CD81 protein on the surface of Hepa 1-6 cells demonstrated.
Conclusions:
- * Established Hepa 1-6 cell clones stably expressing human CD81, a receptor for HCV.
- * Provides a foundation for studying HCV envelope protein interactions with human CD81.
- * Facilitates research on screening for HCV infection blocking drugs and developing HCV infection mouse models.